arrow
S

Sergio A. Quezada

university college london cancer institute
H指数:79
被引数:3.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A preinvasive regulatory T cell axis for lung cancer interception

肺癌拦截的侵袭前调节性T细胞轴

Nature
IF48.5
2026-10-070
OAAI
Preclinical evaluation of nitrated α-synuclein-specific CAR-Treg therapy in Parkinson’s disease

帕金森病中硝化α-突触核蛋白特异性CAR-Treg疗法的临床前评估

2026-08-120
OAAI
Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation

使用机器学习和患者来源的肿瘤外植体验证进行免疫治疗药物靶标鉴定

2026-05-180
OAAI
Synthetic super-enhancers enable precision viral immunotherapy

合成超级增强子实现了精准病毒免疫疗法

Nature
IF48.5
2026-04-080
OAAI
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma

肿瘤内在特征通过前体形成T细胞分化为有症状的多发性骨髓瘤

2026-02-050
OAAI
DURANCE: A phase Ib/II study to assess the safety and activity of durvalumab (MEDI4736) in combination with S-488210/S-488211 vaccine in non-muscle invasive bladder cancer

DURANCE:一项评估 durvalumab(MEDI4736)联合 S-488210/S-488211 疫苗在非肌层浸润性膀胱癌中的安全性与活性的 Ib/II 期研究

2024-12-010
PRE
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution

MHC Hammer揭示了癌症进化中的遗传和非遗传HLA破坏

2024-10-020
OAAI
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models

基因组内异质性在多区域非小细胞肺癌患者来源的异种移植模型中的表现

2024-05-314
OAAI
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer

骨髓和T细胞的空间结构协调肺癌的免疫逃避和临床结果

2024-04-1211
OAAI
Pharmacologic modulation of nonsense-mediated decay induces antitumor immunogenicity in ex vivo patient tumors
2024-03-220
PRE
Pervasive HLA disruption fuels cancer evolution
2024-03-220
PRE
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma

基于人工智能的模型ANORAK改善肺腺癌的组织病理学分级

2024-01-102
OAAI